NeuroNEXT, funded by the National Institutes of Health's (NIH) National Institute of Neurological Disorders and Stroke (NINDS), is the premier NIH ... read more
Yale selected as one of 25 clinical trial sites for treatment of neurological diseases
Yale selected as one of 25 clinical trial sites for treatment of neurological diseases